Prognostic importance of frailty and multimorbidity alongside disease risk in older adults with multiple myeloma

Abstract

Older adults with multiple myeloma (MM) often have frailty and multiple conditions (multimorbidity) at the time of diagnosis, representing a more complex population than younger, healthier patients in clinical trials.